A DRAFT bill proposes that doctors be monitored as to which drugs they prescribe – expensive brand name drugs or cheaper equivalents, reported the daily Pravda.
The bill has sparked mixed feelings in from doctors, health insurers and the Association for the Protection of Patients Rights.
Milan Dragula, of the Slovak Chamber of Doctors, told Pravda that it is impossible to objectively monitor the way doctors prescribe drugs.
The cheaper drugs contain the essential ingredient of the expensive drugs but might contain different extra ingredients to which a patient may be allergic.
The aim of the proposed legislation is to create a report that will determine which health insurer doctors have contracts with.
Compiled by Magdalena MacLeod from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
23. Feb 2005 at 10:58